FAM208b

Jump to navigation Jump to search
VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez

n/a

n/a

Ensembl

n/a

n/a

UniProt

n/a

n/a

RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

Protein FAM208B (family with sequence similarity 208 member b) is a protein that in humans is encoded by the FAM208B gene. The gene is also known as "chromosome 10 open reading frame 18" (c10orf18). FAM208B is expressed throughout the body however its function has not been established. FAM208b has been observed to be differentially regulated in various cancers and throughout developmen. While the exact role of the protein is yet to be established, the significant presence of the protein within humans and throughout the phylogenetic tree depicts a central importance of the gene in normal function.

Gene

The gene is located on chromosome 10 at position 10p15.1.[1] FAM208b is upstream of ankryn repeat and SOCS box containing 13 (ASB13), and downstream of the GDP dissociation inhibitor 2 (GDI2) and nuclear receptor binding factor 2 pseudogene 5 (NRBF2P5).[1] ASBI13 and GDI2 are both found on the opposite strand of FAM208b, while NRBF2P5 is on the same strand.

File:FAM208b.neighborhood.png
The gene neighborhood of FAM208b. GDI2 is upstream on the same strand, while NRBF2P5 is upstream on the reverse strand. ASB13 is directly downstream on the reverse strand.

Homology and Evolution

Paralog

FAM208b has a single paralog, FAM208a. FAM208a is also known as "retinoblastoma-associated protein 140", "Transgene Activation Suppression Protein" (TASOR), "CTCL Tumor Antigen", and "chromosome 3 open reading frame 63" (c3orf63).[2]

Orthologs

FAM208b is conserved only in vertebrates.[3] Orthologs can be found in mammals, reptiles, and amphibians. Distant homologs, including orthologs of the paralog, FAM208a, are observed in bony fish and sharks.

Homologous Domains

FAM208b has highly conserved N- and C- termini and a less conserved central region. Three domains of unknown function (DUFs) are found within the protein, including one DUF 3699 and two DUF 3715. All three DUFs are conserved between species. DUF 3715 is found in the paralog of FAM208b.[4]

File:FAM208banda.allign.png
Alignment of FAM208b and its paralog FAM208a, highlighting identified domains of unknown function: DUF3699 in blue, DUF3715 of FAM208b in yellow, DUF3715 of FAM208a in red, and their overlap in orange.

Evolution

The change in amino acids over time of FAM208b indicates that it is a rapidly evolving gene. The presence of FAM208a but not FAM208b in bony fish and sharks but not FAM208b, indicates that the paralogs split about 325 million years ago.

File:Divergence of FAM208b.png
Relative divergence of FAM208b as compared to Fibrinogen, a rapidly evolving gene, and Cytochrome C, a slowly evolving gene. FAM208b is evolving very rapidly. This is represented as more changes in the amino acid sequence over time.
File:Fam208b.Mammal.Tree.png
Phylogenetic tree depicting predicted evolutionary relationships based on FAM208b sequence similarity from select mammals.

Transcription

Promoter

Two promoter regions for FAM208b can be observed. The earlier promoter region is regulated by numerous transcription factors.[5] The promoter contains binding sites for Ikaros2, Nuclear Factor Y, and at least three binding sites for Pleomorphic adenoma gene 1.

The second promoter region is found within the first intron and encodes a slightly shorter mRNA.[1] This promoter contains multiple binding sites for the FOXP1 transcription factor.

mRNA

The mRNA of the most common peptide (variant x2) is 8699 nucleotides long and includes 22 exons.[6][7][8][9][10]

Binding Proteins

The 5' UTR is bound by the RNA binding proteins RBMX1, FUS, SFRS1, ACO1, and NONO. The 3' UTR is bound by EIF4B, A2BP1, and ZFP36.[11] A single non-coding variant of FAM208b is transcribed. This sequence is partially complimentary to the human gene PCNX1.

Transcript Variants

A total of 20 transcript variants of FAM208b, including one non-coding RNA have been observed.[1] While multiple splice variants are present, 18 exons, composing for 7089 base pairs that code for 2331 amino acids, are present in all coding variants. This constitutes approximately 82.1% of the most common transcript variant (X2), and 95.6% of its polypeptide product. The most commonly skipped exon is Exon 12 (position ch10: 5735304-5735546). Multiple variants have alternative transcription start sites, indicative of an internal promoter sequence.

File:Fam208b.transcript.variants.png
List of all observed FAM208b transcript variants. Exons are thick boxes, introns are thin lines. The NCBI accession number for each variant is given on the right.

Protein

Biochemistry

The primary isoform of FAM208b consists of 2430 amino acids. The total molecular weight is 268.86 kD.[12] FAM208b has an isoelectric point of 5.72.[13] FAM208b has an instability index of 53.64,[14] making it a relatively unstable protein in the unphosphorylated form.

Primary Structure

FAM208b has a unique amino acid composition. An above-average proportion of serine residues are observed (11.1%). This indicates a potential role in intracellular signaling.[15]

File:FAM208b.AA.distribution.png
Comparison of the amino acid composition of FAM208b and the total distribution of amino acids in all proteins. FAM208b has an above average composition of serine residues.

Secondary Structure

FAM208b is predicted to have multiple alpha-helical domains.[16] It is predicted that 25% of the protein forms alpha-helices, 15% forms beta-strands, and 60% is random coil. The various DUF domains are predicted to have variable structure. DUF3699 consists of two helices and four beta-strands. The N-terminal DUF3715 appears to form a stretch of random coil, while the C-terminal DUF3715 has two helices and four beta-strands.

File:DUF3699.png
Predicted structure of FAM208b's DUF3699 domain.
File:DUF3715.1.png
Predicted structure of FAM208b's first DUF3715 domain. It appears to be entirely disordered.
File:DUF3715.2.png
Predicted Structure of FAM208b's second DUF3715 domain.

Tertiary Structure

A tertiary structure has not yet been confirmed by X-ray crystallography. Predictions of tertiary structure indicate a modular protein, composed of three modules connected by random coil.

File:FAM208b.3D.png
3D structure prediction of FAM208b.

Post-Translational Modifications

Phosphorylation

FAM208b has 13 experimentally confirmed phosphorylation sites on serine residues.[17][18][19][20] The high serine content of FAM208b suggests a role in intracellular signaling.

SUMOylation

FAM208b has potential for SUMOylation[21] SUMOylation has been observed to play a role in nuclear transport, which would aid FAM208b's localization prediction.

Glycosylation

FAM208b is predicted to be an intracellular protein, indicating that it is not glycosylated.

SubCellular Location

FAM208b is predicted to be localized to the cytosol or nucleus. The peptide sequence lacks a signal sequence either at the N-terminus or internally.[22] No transmembrane domains have been observed or predicted,[23] indicating that FAM208b is not secreted or found in the cell membrane, and is very likely to be intracellular. A Nuclear Localization Signal is observed at amino acids 393-403.[24] The NLS is highly conserved in mammals, birds, and reptiles.

File:FAM208b.NLS.MSA.png
Multiple Sequence Alignment between various mammalian groups of the Nuclear Localization Signal of FAM208b, indicating that the protein is likely transported to the cell nucleus.

Clinical Significance

Development

FAM208b expression is observed to decrease over the course of development.[25] Peak expression is observed in the blastocyst. A sharp decline in expression is observed at the fetal stage, after which expression is maintained at constant levels through adulthood.

Pathology

FAM208b has been observed to be correlated in a variety of cancers. The locus of FAM208b (10p15.1) was identified as an aberration site present in translocation-positive Follicular lymphoma but not Nodal Marginal Zone Lymphoma.[26] FAM208b has also been identified as being upregulated significantly and prominently in Non-Hodgkin lymphoma cells.[27] FAM208b has been identified as a hub gene of Stage IV colorectal cancer.[28] A fusion of FAM208b and PLEKHB1 has been validated as candidate for fusion of chromosomes 10 and 11 in Donor Cell Leukemia.[29] FAM208b has also been separately observed to be differentially expressed in a variety of cancers. A decrease in transcription of FAM208b has been observed in adrenal cancer, bladder cancer, breast cancer, gastrointestinal cancer, glial cancer, kidney cancer, lymph cancer, skin cancer, muscle cancer, and uterine cancer. An increase in transcription of FAM208b has been observed in cervical cancer, leukemia, liver cancer, lung cancer, and prostate cancer.[30]

FAM208b has also been found to be expressed at higher levels in Acute Macular Degeneration.[31][32]

FAM208b has been observed to be downregulated in bronchial epithelial cells infected by respiratory syncytial virus and has been postulated as a biosignature of the infection.[33]

References

  1. ↑ 1.0 1.1 1.2 1.3 "FAM208b". NCBI-Gene. NCBI. Retrieved 27 April 2018.
  2. ↑ "Aliases for FAM208a Gene". FAM208a. GeneCards. Retrieved 27 April 2018.
  3. ↑ "Basic Local Alignment Search Tool". BLAST. NCBI. Retrieved 28 April 2018.
  4. ↑ "Protein of unknown function DUF3715". Protein sequence analysis & classification. InterPro. Retrieved 1 May 2018.
  5. ↑ "Annotation and Analysis". ElDorado. Genomatix. Retrieved 27 April 2018.
  6. ↑ Oshikawa M, Tsutsui C, Ikegami T, Fuchida Y, Matsubara M, Toyama S, Usami R, Ohtoko K, Kato S (August 2011). "Full-length transcriptome analysis of human retina-derived cell lines ARPE-19 and Y79 using the vector-capping method". Investigative Ophthalmology & Visual Science. 52 (9): 6662–70. doi:10.1167/iovs.11-7479. PMID 21697133.
  7. ↑ Savage SA, Mirabello L, Wang Z, Gastier-Foster JM, Gorlick R, Khanna C, et al. (July 2013). "Genome-wide association study identifies two susceptibility loci for osteosarcoma". Nature Genetics. 45 (7): 799–803. doi:10.1038/ng.2645. PMID 23727862.
  8. ↑ Sahni N, Yi S, Taipale M, Fuxman Bass JI, Coulombe-Huntington J, Yang F, et al. (April 2015). "Widespread macromolecular interaction perturbations in human genetic disorders". Cell. 161 (3): 647–660. doi:10.1016/j.cell.2015.04.013. PMID 25910212.
  9. ↑ Yang X, Coulombe-Huntington J, Kang S, Sheynkman GM, Hao T, Richardson A, et al. (February 2016). "Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing". Cell. 164 (4): 805–17. doi:10.1016/j.cell.2016.01.029. PMC 4882190. PMID 26871637.
  10. ↑ Zhong Q, Pevzner SJ, Hao T, Wang Y, Mosca R, Menche J, et al. (April 2016). "An inter-species protein-protein interaction network across vast evolutionary distance". Molecular Systems Biology. 12 (4): 865. PMID 27107014.
  11. ↑ "The Database of RNA-binding protein specificities". RBPDB. University of Toronto. Retrieved 1 May 2018.
  12. ↑ Stothard, Paul. "Protein Molecular Weight". Bioinformatics. Scilico. Retrieved 1 May 2018.
  13. ↑ Kozlowski, Lukasz P. "Isoelectric Point Calculator". Isoelectric. Biology Direct.
  14. ↑ "ProtParam". Expasy. Swiss Institute of Bioinformatics. Retrieved 1 May 2018.
  15. ↑ Yaffe MB, Smerdon SJ (March 2001). "PhosphoSerine/threonine binding domains: you can't pSERious?". Structure. 9 (3): R33–8. PMID 11286893.
  16. ↑ "GOR4 secondary structure prediction". PRABI. Rhone-Alpes Bioinformatics Center. Retrieved 1 May 2018.
  17. ↑ Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H (January 2014). "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome". Journal of Proteomics. 96: 253–62. doi:10.1016/j.jprot.2013.11.014. PMID 24275569.
  18. ↑ Dephoure N, Zhou C, Villén J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP (August 2008). "A quantitative atlas of mitotic phosphorylation". Proceedings of the National Academy of Sciences of the United States of America. 105 (31): 10762–7. doi:10.1073/pnas.0805139105. PMC 2504835. PMID 18669648.
  19. ↑ Zhou H, Di Palma S, Preisinger C, Peng M, Polat AN, Heck AJ, Mohammed S (January 2013). "Toward a comprehensive characterization of a human cancer cell phosphoproteome". Journal of Proteome Research. 12 (1): 260–71. doi:10.1021/pr300630k. PMID 23186163.
  20. ↑ Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, Jensen LJ, Gnad F, Cox J, Jensen TS, Nigg EA, Brunak S, Mann M (January 2010). "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis". Science Signaling. 3 (104): ra3. doi:10.1126/scisignal.2000475. PMID 20068231.
  21. ↑ "SUMOplot™ Analysis Program". SUMOplot. ABGENT. Retrieved 1 May 2018.
  22. ↑ "SignalP". DTU Bioinformatics. Department of Bio and Health Informatics. Retrieved 27 April 2018.
  23. ↑ "TMHMM". DTU Bioinformatics. Department of Bio and Health Informatics. Retrieved 27 April 2018.
  24. ↑ Kosugi S, Hasebe M, Tomita M, Yanagawa H (June 2009). "Systematic identification of cell cycle-dependent yeast nucleocytoplasmic shuttling proteins by prediction of composite motifs". Proceedings of the National Academy of Sciences of the United States of America. 106 (25): 10171–6. doi:10.1073/pnas.0900604106. PMID 19520826.
  25. ↑ "EST Profile - Hs.610717". www.ncbi.nlm.nih.gov. NCBI. Retrieved 6 May 2018.
  26. ↑ Krijgsman O, Gonzalez P, Ponz OB, Roemer MG, Slot S, Broeks A, Braaf L, Kerkhoven RM, Bot F, van Groningen K, Beijert M, Ylstra B, de Jong D (December 2013). "Dissecting the gray zone between follicular lymphoma and marginal zone lymphoma using morphological and genetic features". Haematologica. 98 (12): 1921–9. doi:10.3324/haematol.2013.085118. PMID 23850804.
  27. ↑ Schrader A, Meyer K, von Bonin F, Vockerodt M, Walther N, Hand E, Ulrich A, Matulewicz K, Lenze D, Hummel M, Kieser A, Engelke M, Trümper L, Kube D (December 2012). "Global gene expression changes of in vitro stimulated human transformed germinal centre B cells as surrogate for oncogenic pathway activation in individual aggressive B cell lymphomas". Cell Communication and Signaling. 10 (1): 43. doi:10.1186/1478-811X-10-43. PMID 23253402.
  28. ↑ Asghari M, Abazari MF, Bokharaei H, Aleagha MN, Poortahmasebi V, Askari H, Torabinejad S, Ardalan A, Negaresh N, Ataei A, Pazooki P, Poorebrahim M (March 2018). "Key genes and regulatory networks involved in the initiation, progression and invasion of colorectal cancer". Future Science OA. 4 (3): FSO278. doi:10.4155/fsoa-2017-0108. PMID 29568567.
  29. ↑ Taniguchi R, Muramatsu H, Okuno Y, Suzuki K, Obu S, Nakatochi M, Shimamura T, Takahashi Y, Horikoshi Y, Watanabe K, Kojima S (February 2018). "Comprehensive genetic analysis of donor cell derived leukemia with KMT2A rearrangement". Pediatric Blood & Cancer. 65 (2). doi:10.1002/pbc.26823. PMID 28921816.
  30. ↑ Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB (April 2004). "A gene atlas of the mouse and human protein-encoding transcriptomes". Proceedings of the National Academy of Sciences of the United States of America. 101 (16): 6062–7. doi:10.1073/pnas.0400782101. PMID 15075390.
  31. ↑ Newman AM, Gallo NB, Hancox LS, Miller NJ, Radeke CM, Maloney MA, Cooper JB, Hageman GS, Anderson DH, Johnson LV, Radeke MJ (February 2012). "Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks". Genome Medicine. 4 (2): 16. doi:10.1186/gm315. PMID 22364233.
  32. ↑ Abu-Asab MS, Salazar J, Tuo J, Chan CC (2013). "Systems Biology Profiling of AMD on the Basis of Gene Expression". Journal of Ophthalmology. 2013: 453934. doi:10.1155/2013/453934. PMID 24349763.
  33. ↑ Gardinassi LG (2016). "A Cross-Study Biomarker Signature of Human Bronchial Epithelial Cells Infected with Respiratory Syncytial Virus". Advances in Virology. 2016: 3605302. doi:10.1155/2016/3605302. PMID 27274726.
Retrieved from "https://www.wikidoc.org/index.php?title=FAM208b&oldid=1527456"